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VALIDATION OF THE BRAZILIAN VERSION 
OF THE BERG BALANCE SCALE FOR PATIENTS 
WITH PARKINSON’S DISEASE
Paula L. Scalzo1, Isabella C. Nova2, Mônica R. Perracini3, Daniel R.C. Sacramento3,  
Francisco Cardoso4, Henrique B. Ferraz5, Antonio Lúcio Teixeira6
Abstract – Background: Changes in balance occur with the progression of Parkinson’s disease (PD).  Objective: 
To validate the Brazilian version of the Berg Balance Scale (BBS) for PD patients, determining its reliability and 
internal consistency and correlating it with PD-specific instruments.  Method: We evaluated 53 patients (M/F 
37/16, mean age±SD, 62±7.9 years) with PD (mean±SD, 7.8±4.4 years). Unified Parkinson’s Disease Rating Scale 
(UPDRS), Schwab and England Scale (S&E), Hoehn and Yahr Staging Scale (HY) and BBS were used to assess 
patients. Statistical analyses for inter-rater reliability, internal consistency and correlations among BBS, UPDRS, 
S&E and HY were performed.  Results: The mean scores±SD on UPDRS and BBS were, respectively, 41.6±17.8 
and 47.2±8.2. The median on S&E and HY scales were 80% and 2.5, respectively. The BBS presented a high intra-
class correlation coefficient (ICC=0.84) and internal consistency (Cronbrach’s α=0.92). There was a statistically 
significant correlation between BBS and disease duration (rs= –0.520, p<0.001), UPDRS subscales II and III (rs= 
–0.467, p=0.011; rs= –0.374, p=0.046, respectively), stage of disease (HY; rs= –0.507, p<0.001) and the activities 
of daily living (S&E; rs=0.492, p<0.001).  Conclusion: The BBS is a promising tool for the assessment of balance 
in PD, correlating with the stage of disease and the level of independence.
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Validação da versão brasileira da Escala de Equilíbrio de Berg para pacientes com a doença de Parkinson 
Resumo – Alterações de equilíbrio ocorrem com a progressão da doença de Parkinson (DP).  Objetivo: Validar 
a versão brasileira da Escala de Equilíbrio de Berg (EEB) para pacientes com DP, determinando a confiabilidade, 
a consistência interna e correlacionando com instrumentos específicos da DP.  Método: Foram avaliados 53 
pacientes (H/M 37/16, idade média±DP, 62±7,9 anos) com DP (media±DP, 7,8±4,4 anos). Escala de Graduação 
Unificada da Doença de Parkinson (UPDRS), Escala de Schwab e England (S&E), Escala de Estágios de Hoehn e Yahr 
(HY) e EEB foram utilizadas. Análise estatística para confiabilidade entre examinadores, consistência interna e 
correlações entre EEB, UPDRS, S&E e HY foram realizadas.  Resultados: Os escores médios±DP nas escalas UPDRS 
e EEB foram, respectivamente, 41,6±17,8 e 47,2±8,2. A mediana nas escalas S&E e HY foram 80% e 2,5. A EEB 
mostrou ter alto coeficiente de correlação intraclasse (ICC=0,84) e consistência interna (α de Cronbach=0,92). 
Houve correlação estatisticamente significativa entre EEB e a duração da doença (rs= –0,520, p<0,001), sub-
escalas II e III do UPDRS (rs= –0,467, p=0,011; rs= –0,374, p=0,046, respectivamente), estágio da doença (HY; rs= 
–0,507, p<0,001), com as atividades da vida diária (S&E; rs= 0,492; p<0,001).  Conclusão: A EEB é um instrumento 
promissor para avaliar o equilíbrio na DP, correlacionando-se com o estágio da doença e o nível de independência.
PALAVRAS-CHAVE: doença de Parkinson, instabilidade postural, Escala de Equilíbrio de Berg.
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Parkinson’s disease (PD) is the most common neuro-
degenerative movement disorder, affecting 0.3% of the 
general population1. Pathologically, it is characterized by 
the progressive and irreversible loss of the dopaminer-
gic neurons from substantia nigra pars compacta (SNpc). 
Clinically, PD is characterized by motor dysfunctions, in-
cluding bradykinesia, resting tremor and rigidity. Postur-
al instability occurs with the progress of the disease, and 
subsequently it causes falls in patients, which in turn re-
stricts mobility, functional independence and social par-
ticipation2-5. Once balance deteriorates in PD, it is impor-
tant to have a quantifiable tool that health care profes-
sionals can use to monitor these changes. The Berg Bal-
ance Scale (BBS) has been the main instrument used to 
identify and to evaluate balance impairment in different 
populations, although this scale was originally designed 
to assess the risk of falling in elderly patients6-9. The BBS 
is a 14-item scale that measures static and dynamic stand-
ing balance6,7. Each item is scored on a five-point ordi-
nal scale ranging from 0 (unable to perform) to 4 (normal 
performance). The total score range is 0 to 56 and high-
er scores denote better balance. Scores of 0 to 20 refer 
to those patients restricted to a wheelchair; 21 to 40 re-
fer to assistance during the gait and 41 to 56 points cor-
respond to independence. 
Psychometric properties of this scale have been exam-
ined by various researchers. These studies showed strong 
internal consistency and inter- and intra-rater reliability in 
neurological diseases, such as stroke and PD8,10. Nova et al. 
demonstrated that the BSS had enough sensitivity to de-
tect balance changes during on-off fluctuation in PD pa-
tients on levodopa therapy11. Recently, Qutubuddin et al. 
validated the English version of the BBS for PD after eval-
uating 38 male patients12. BBS scores showed significant 
correlations with PD-specific instruments that measure 
motor functioning, stage of disease and daily living capac-
ity. These researchers proposed that the BBS may be used 
for screening and ongoing assessment for PD. Franchigno-
ni et al. proposed to determine unidimensionality, internal 
construct validity and the rating scale for PD patients13. 
The aim of the present study was to assess the clinim-
etric properties of the Brazilian version of the BBS in pa-
tients with idiopathic PD. For this purpose, we assessed 
inter-rater reliability and internal consistency, and corre-
lated BBS with PD-specific instruments. 
METHOD
Demographic and clinical data were collected from 53 pa-
tients with PD from the Movement Disorders Clinic of the Fed-
eral University of Minas Gerais (UFMG) and the Movement Dis-
orders Clinic of the Federal University of São Paulo (UNIFESP). 
Local ethics committees approved the study and all participants 
provided written consent prior to data collection. 
Eligibility for the study was determined by the presence of a 
clinical diagnosis of PD and findings of up to stage 3 on the Modi-
fied Hoehn and Yahr Staging Scale (HY). Participants were includ-
ed if they were able to stand and walk independently without 
the use of an assistive device. Participants were excluded if they 
had another neurological disease or orthopedic impairment.
Demographic and clinical assessments were completed on 
the same day. All patients were assessed after the use of levopo-
da, i.e. at “on” period. The Brazilian version of the Mini Mental 
State Examination (MMSE) was used to assess cognitive func-
tion14. The PD-specific instruments used were: Unified Parkinson’s 
Disease Rating Scale (UPDRS), Modified Hoehn and Yahr Staging 
Scale and Modified Schwab and England Capacity for Daily Living 
Scale (S&E). These instruments were applied by an experienced 
neurologist. The UPDRS is currently the most widely accepted 
scale for measuring the different components of PD. It has 3 sub-
scales: UPDRS I – mentation, behavior and mood (range 0–16); 
UPDRS II – activities of daily living (ADL) (range 0–52) and UP-
DRS III – motor examination (range 0–108). Each item is scored 
on a scale from 0 to 4. A total of 176 points is possible with 176 
representing maximal (or total) disability and 0 representing no 
disability15-17. The HY classifies PD patients in five stages accord-
ing to body distribution of symptoms and dependency. Patients 
in stage I are mildly affected, while in stage V they are bedrid-
den15-17. The S&E is widely used to assess disability in performing 
ADL in people with PD. It uses a percentage scale divided into 
deciles, with 100% representing completely normal and inde-
pendent functioning and 0% representing total helplessness15-17.
The Brazilian version of the BBS was used to measure bal-
ance abilities18 and was completed by two other examiners who 
received identical training. BBS consists of 14 items that evalu-
ate balance abilities during tasks involving sitting, standing and 
changing position. Scoring is based on the individual’s ability to 
perform each task independently and/or meet certain time or 
distance requirements. The scale consists of 14 tasks common 
in everyday life. The items test the subject’s ability to maintain 
positions or movements of increasing difficulty by diminishing 
the base of support from sitting to standing to single leg stance. 
The ability to change positions is also assessed. The 14 items are, 
in this order: sitting to standing (B1); standing unsupported (B2); 
sitting with back unsupported but feet supported on the floor 
or on a stool (B3); standing to sitting (B4); transfer (B5); stand-
ing unsupported with eyes closed (B6); standing unsupported 
with feet together (B7); reaching forward with outstretched arm 
while standing (B8); picking up an object from the floor from a 
standing position (B9); turning to look behind over left and right 
shoulders while standing (B10); turning 360 degrees (B11); plac-
ing alternate feet on step or stool while standing unsupport-
ed (B12); standing unsupported with one foot in front (B13) and 
standing on one leg (B14)6,7. 
Statistical analyses were performed with SPSS v12.0 software 
for Windows. Mean and standard deviation (SD) were calculated 
for each of the measures. Intra-class coefficient correlation (ICC) 
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was calculated to evaluate inter-rater reliability and Chronbach’s 
α was calculated to evaluate internal consistency of the total 
BBS score. Correlation analyses between PD-specific instruments 
and the BBS were calculated using Spearman’s rank correlation 
coefficient, and such correlation indicated the criterion-related 
validity. The magnitude of correlation was classified according 
to Munro (low=0.26–0.49; moderate=0.50–0.69; high=0.70–0.89; 
very high=0.90–1.00) for interpretation of the correlation coef-
ficients19. Statistical significance was set at p<0.05. 
RESULTS
The study sample was composed of 53 patients, in-
cluding 16 (30.2%) women and 37 (69.8%) men. Severity 
of disease according to the UPDRS was moderate in most 
participants (Table 1). Patient distribution on the HY scale 
generally showed mild-to-moderate disease involvement: 
stage 1, 3 patients (5.7%); stage 1.5, 3 patients (5.7%); stage 
2, 15 patients (28.3%); stage 2.5, 17 patients (32%) and stage 
3, 15 patients (28.3%). Percentile ratings on the S&E like-
wise suggested the relatively high and generally indepen-
dent functioning of the patients: rating of 100%, 2 patients 
(3.8%); rating of 90%, 18 patients (33.9%), rating of 80%, 17 
patients (32.1%); rating of 70%, 14 patients (26.4%); rating 
of 60% and 50%, 1 patient (1.9%).
Regarding the psychometric properties of the BBS, the 
scale showed high inter-rater reliability (ICC=0.84) and in-
ternal consistency (Cronbach’s α=0.92). There was a sta-
tistically significant negative correlation between the 
BBS and disease duration, ADL and motor examination 
subscales of the UPDRS and stages of disease when as-
sessed by the HY. There was a statistically significant pos-
itive correlation between the BBS and the worst level of 
functional independence evidenced by the S&E (Table 2). 
There were statistically significant correlations among all 
14 items of the BBS (Table 3). The magnitude of the corre-
lation between individual BBS items was moderate.
Exploratory factorial analysis using the principal com-
ponents method found that two factors accounted for 
64.6% of total variance of the BBS. Factor 1 was responsi-
ble for 37.1% of total variation and factor 2 was responsi-
ble for 27.4% of total variation. Table 4 shows the factorial 
loads for each question for two factors from the BBS.
DISCUSSION 
Despite the BBS not being specific to PD, this instru-
ment has been a valid tool for screening and assessing PD 
patients12. Landers et al. suggested that the BBS is most ef-
fective at discriminating PD fallers from non-fallers20. 
Our results showed higher inter-rater reliability and 
internal consistency of the BBS in PD patients. Only two 
Table 1. Demographic and clinical features of 53 patients with 
Parkinson’s disease (PD).
Variables N (%) or Mean ± SD (range)
Gender (male/female) 37 (69.8%) / 16 (30.2%)
Age (years) 62.0±7.9 (46–82)
Age of PD onset (years) 54.6±8.6 (40–77)
Disease duration (years) 7.8±4.4 (2–20)
MMSE 25.1±3.3 (18–30)
UPDRS 
  UPDRS I
  UPDRS II
  UPDRS III
41.6±17.8 (12–91)
3.2±2.4 (0–10)
14.8±6.9 (3–27)
31.3±11.8 (9–54)
HY* 2.5 (1–3)
S&E* 80% (50–100%)
BBS 47.2±8.2 (27–56)
*Median (range). SD: standard deviation; MMSE: Mini-Mental State 
Examination; UPDRS: Unified Parkinson’s Disease Rating Scale; HY: Hoehn-
Yahr Staging Scale; S&E: Schwab and England Activities of Daily Living 
Scale; BBS: Berg Balance Scale. 
Table 2. Spearman’s rank correlation coefficient (rs) and p-value between demographic, clinical 
variables, and BBS; and classification of Munro for the magnitude of the correlations18.
Variables
BBS
rs p-Value Classification
Age (years) –0.016 0.911 No correlation
Age of PD onset (years) 0.193 0.171 No correlation
Disease duration (years) –0.520 <0.001 Moderate
UPDRS 
  UPDRS I
  UPDRS II
  UPDRS III
–0.067
–0.190
–0.467
–0.374
0.635
0.261
0.011
0.046
No correlation
No correlation
Low correlation
Low correlation
HY –0.507 <0.001 Moderate correlation
S&E 0.492 <0.001 Low correlation
PD: Parkinson disease; UPDRS: Unified Parkinson’s Disease Rating Scale; HY: Hoehn-Yahr Staging Scale; S&E: 
Schwab and England Activities of Daily Living Scale; BBS: Berg Balance Scale. 
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Table 3. Spearman’s rank correlation coefficient (rs) and p-value between BBS items.
B1 B2 B3 B4 B5 B6 B7 B8 B9 B10 B11 B12 B13 B14
B2 .582
<0.001
B3 .351
0.009
.807
<0.001
B4 .648
<0.001
.622
<0.001
.465
<0.001
B5 .580
<0.001
.689
<0.001
.620
<0.001
.657
<0.001
B6 .561
<0.001
.829
<0.001
.785
<0.001
.566
<0.001
.639
<0.001
B7 .574
<0.001
.875
<0.001
.798
<0.001
.582
<0.001
.662
<0.001
.986
<0.001
B8 .456
<0.001
.339
.011
.285
.035
.573
<0.001
.453
.001
.376
.005
.389
.003
B9 .582
<0.001
.782
<0.001
.713
<0.001
.505
<0.001
.643
<0.001
.901
<0.001
.910
<0.001
.398
.003
B10 .274
.043
.281
.037
.256
.060
.260
.055
.256
.059
.333
.013
.351
.009
.114
.406
.320
.017
B11 .322
.017
.436
.001
.366
.006
.524
<0.001
.434
.001
.475
<0.001
.481
<0.001
.393
.003
.465
<0.001
.163
.233
B12 .563
<0.001
.616
<0.001
.513
<0.001
.488
<0.001
.683
<0.001
.690
<0.001
.695
<0.001
.406
.002
.690
<0.001
.370
.005
.451
<0.001
B13 .502
<0.001
.641
<0.001
.574
<0.001
.674
<0.001
.609
<0.001
.671
<0.001
.673
<0.001
.549
<0.001
.574
<0.001
.238
.080
.558
<0.001
.481
<0.001
B14 .310
.021
.504
<0.001
.416
.002
.487
<0.001
.548
<0.001
.622
<0.001
.610
<0.001
.375
.005
.530
<0.001
.218
.110
.563
<0.001
.601
<0.001
.613
<0.001
Table 4. Factorials loads for each item in two factors extracted from BBS by varimax rotation.
Item description of the BBS
Factor
1 2
B7 – Standing unsupported with feet together .896 .274
B9 – Pick up object from the floor from a standing position .860 .235
B6 – Standing unsupported with eyes closed .849 .294
B2 – Standing unsupported .834 .350
B3 – Sitting with back unsupported but feet supported on floor or on a stool .773 .256
B12 – Place alternate foot on step or stool while standing unsupported .697 .552
B10 – Turning to look behind over left and right shoulders while standing .426 .130
B4 – Standing to sitting .087 .817
B13 – Standing unsupported with one foot in front .523 .699
B8 – Reaching forward with outstretched arm while standing .151 .681
B5 – Transfers .498 .669
B11 – Turning 360 degrees .263 .668
B14 – Standing on one leg .442 .609
B1 – Sitting to standing .394 .478
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studies have assessed the clinimetric properties of the BBS 
in patients with idiopathic PD12,13. Qutubuddin et al. mea-
sured the criterion-related validity of the BBS in 38 men, 
correlating the BBS with PD-specific instruments12. Franchi-
gnoni et al. assessed 57 patients with PD, calculated Cron-
brach’s α and correlated the BBS with instruments used 
in PD13. Internal consistency in that study was also high13. 
Our results showed that balance performance was 
negatively affected by longer duration of disease, severity 
of symptoms and greater impairment on subscales II and 
III of the UPDRS, advanced stage of disease when assessed 
by HY stages and worst level of functional independence 
evidenced by the S&E. This is in line with previous works 
that have demonstrated similar findings in PD patients, 
but only Franchignoni et al have showed correlation be-
tween the BBS and the subscale II of the UPDRS10,12,21. As 
PD progresses, significant changes in posture and predis-
position to fall may develop. This predisposition to fall 
may induce psychological reactions characterized by fear 
of future falling5,22. This fear of falling can be maladaptive 
when it compels patients to restrict their mobility, inde-
pendence and social participation, leading to further lim-
itation and gradual physical disability.
As seen in Table 4, items directly related to static bal-
ance (items B2, B3, B6, B7, B9, B10, B12) belonged to fac-
tor 1. The items related to dynamic balance (B1, B4, B5, B8, 
B11, B13, B14) had the highest load factor in factor 2. These 
items require major postural adjustments, both anticipa-
tory and continuous, when compared to items of compo-
nent 1. Both factors accounted for a great percentage of 
total variance of the BBS and their items were grouped in 
a logical way. However some minor inconsistencies should 
be noticed. Item B3 showed ceiling effect in 83% of pa-
tients. Many patients (52%) in item B11 were able to turn 
to both sides safely, but slowly, which may have been in-
fluenced mainly by bradykinesia, not by the lack of bal-
ance. Item B12 also loaded on factor 2, but less significant-
ly. Accordingly, Franchignoni et al. suggested that some 
items on this scale should be revised to improve its valid-
ity in PD patients. 
In conclusion, the instrument seemed to be suitable 
for the assessment of PD patients. BBS correlated with the 
severity of symptoms, the stage of disease and the level 
of independence. Studies evaluating the effect of phar-
macological treatments and/ or rehabilitation techniques 
on PD should use BBS. 
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